A detailed history of Bestgate Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bestgate Wealth Advisors, LLC holds 1,810 shares of ABBV stock, worth $344,515. This represents 0.65% of its overall portfolio holdings.

Number of Shares
1,810
Holding current value
$344,515
% of portfolio
0.65%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$164.99 - $203.87 $298,631 - $369,004
1,810 New
1,810 $322 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $337B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bestgate Wealth Advisors, LLC Portfolio

Follow Bestgate Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bestgate Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bestgate Wealth Advisors, LLC with notifications on news.